Mast Cell Protease 7 Inhibitors
Mast cell protease 7 (MCP-7) inhibitors are part of a specialized group of compounds designed to modulate the activity of a particular enzyme known as mast cell protease 7, which is a serine protease predominantly expressed by mast cells. Serine proteases are a broad class of proteolytic enzymes characterized by a serine residue in their active site, which plays a key role in the cleavage of peptide bonds in proteins. The specificity of these enzymes is typically governed by the recognition of certain amino acid sequences near the cleavage site. Mast cell proteases, including MCP-7, are stored in the granules of mast cells and are released upon mast cell activation. These enzymes are believed to be involved in a variety of biological processes due to their ability to cleave and modulate the function of multiple substrates, including other enzymes, receptor molecules, and structural proteins.
MCP-7 inhibitors would be molecules that selectively bind to the active site or another critical region of the mast cell protease 7 enzyme, preventing its interaction with substrates and thus inhibiting its proteolytic activity. The design of such inhibitors often relies on knowledge of the enzyme's structure and the mechanisms by which it interacts with its substrates. Inhibitors could be small molecules, peptides, or antibody-based compounds that either block the active site or alter the conformation of the enzyme in such a way that it becomes unable to perform its normal catalytic function. The specificity of MCP-7 inhibitors is crucial, as off-target effects on other serine proteases could lead to unintended consequences due to the extensive family of serine proteases and their wide range of biological functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Marimastat is a broad-spectrum matrix metalloproteinase inhibitor that can affect tissue remodeling and fibrosis, processes that can modulate mast cell activity and consequently the release or activation of proteases such as Mast Cell Protease 7. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
Gabexate Mesilate is a serine protease inhibitor that can interfere with various proteases in the coagulation cascade and inflammatory response, potentially altering the activation and recruitment of mast cells and their associated proteases. | ||||||
Apremilast | 608141-41-9 | sc-480062 | 5 mg | $444.00 | ||
Apremilast is a phosphodiesterase 4 inhibitor that raises intracellular cAMP levels, which can have an inhibitory effect on mast cell degranulation and therefore reduce the release of various proteases, potentially including Mast Cell Protease 7. | ||||||
Zileuton | 111406-87-2 | sc-204417 sc-204417A sc-204417B sc-204417C | 10 mg 50 mg 1 g 75 g | $84.00 $307.00 $369.00 $1254.00 | 8 | |
Zileuton is a 5-lipoxygenase inhibitor that can limit the production of leukotrienes, molecules that are involved in inflammatory responses and can influence mast cell activation, potentially reducing protease release including Mast Cell Protease 7. | ||||||
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $31.00 $103.00 $283.00 $978.00 | 2 | |
Tranilast is an anti-allergic compound that can inhibit the release of chemical mediators from mast cells, thereby potentially decreasing the activity of proteases such as Mast Cell Protease 7 that are released during these processes. | ||||||
Amlexanox | 68302-57-8 | sc-217630 | 10 mg | $160.00 | 2 | |
Amlexanox inhibits the release of histamine and leukotrienes from mast cells, which could lead to a reduction in the activity and release of proteolytic enzymes such as Mast Cell Protease 7 by stabilizing mast cell membranes. | ||||||